**SEO Title:** Trump Proposes Prescription Drug Price Cuts Linked to Global Rates
**Meta Description:** Donald Trump aims to reduce U.S. prescription drug prices by tying them to the lowest international rates, with support from billionaire Bill Ackman.
**URL Slug:** trump-prescription-drug-price-cuts
**Headline:** Trump Unveils Plan to Lower Prescription Drug Prices by Aligning with Global Rates
On May 12, President Donald Trump announced a proposal to reduce prescription drug costs in the United States by linking domestic prices to the lowest rates offered by pharmaceutical companies in international markets. In a detailed post on his social media platform, Truth Social, Trump stated he would sign an executive order at 9 AM (6:30 PM IST) in Washington, D.C. This initiative has garnered support from billionaire investor Bill Ackman, who suggested that Trump’s proposal aligns with his own earlier recommendations.
Ackman expressed his belief that Trump must have appreciated his idea, referencing a post he made in March advocating for U.S. drug prices to be tied to international rates. In that post, Ackman argued that making it illegal for drug companies to sell the same drugs abroad at lower prices than in the U.S. would create a globally negotiated price, ultimately benefiting American consumers.
In his recent comments, Ackman emphasized that the U.S. has been subsidizing global drug costs, contributing to the nation’s significant national debt. He commended Trump for being the first president to address this issue, stating, “President Donald Trump is the first president in history to rectify the situation. He deserves enormous credit for doing so.”
Trump highlighted the longstanding disparity in drug prices, questioning why medications in the U.S. are often five to ten times more expensive than the same drugs produced in other countries. He criticized pharmaceutical companies for attributing high prices to research and development costs, suggesting that American consumers have unfairly borne these expenses.
The president’s proposal aims to challenge the status quo and address the financial burden on American consumers, a move that has been met with both support and skepticism. As the situation develops, it remains to be seen how this initiative will impact the pharmaceutical industry and drug pricing in the U.S.
**FAQ Section:**
**Q: How will Trump’s proposal affect prescription drug prices in the U.S.?**
A: Trump’s proposal aims to lower prescription drug prices by linking them to the lowest international rates, potentially reducing costs for American consumers.
